Europe Advanced Wound Care Market

September 2017 | 150 pages | ID: E141B7AD282EN
Data Bridge Market Research

Abstracts

In this region, The Europe advanced wound care market is expected to reach USD 5,144.5 million by 2024, from USD 3,224.6 million in 2016 growing at a CAGR of 6.1% in the forecast period 2017 to 2024.

Based on geography, the Europe advanced wound care market is segmented into 11 geographical regions, such as,

• Germany,
• France,
• United Kingdom,
• Italy,
• Spain,
• Russia,
• Turkey,
• Belgium,
• Netherlands,
• Switzerland and
• Rest of Europe.

Europe advanced wound care market competition by top players including

• Smith and Nephew Plc.
• Acelity L.P., Inc.
• Mölnlycke Health Care
• Coloplast Corp.
• ConvaTec, Inc.
• 3M Health care
• Medtronic
• Integra Lifesciences Corporation

The Europe advanced wound care market is segmented into three product types, namely, dressing, biologics, and therapy devices.

• Based on dressing type, the market is segmented into foam dressing, hydrogels, film dressings, alginates, wound contact layer and super absorbent dressing.
• Based on biologics type, the market is segmented synthetic into skin grafts, growth factors, allografts and xenografts.
• Based on wound care growth factor type, the market is segmented into platelet derived growth factor (PDGF), platelet rich plasma (PRP), epidermal growth factor (EGF), basic fibroblast growth factor (BFGF), granulocyte colony stimulating factor (G-CSF), talactoferrin ALFA, thrombin peptide (TP508) and keratinocyte growth factor (KGF
• Based on wound care therapy devices type, the market is segmented into negative pressure wound therapy (NPWT), pressure relief devices (PRD), wound debridement devices, hyberbaric oxygen chambers and physical therapies
• Based on NPWT type, the market is segmented into stand-alone NPWT devices, portable NPWT devices and disposable NPWT devices.
• Based on PRD type, the market is segmented into mattress and bed.
• Based on hyberbaric oxygen chambers type, the market is segmented into monoplace, multiplace and topical.
• Based on wound debridement devices type, the market is segmented into hydrosurgical, ultrasound, mechanical among others.
• Based on physical therapies type, the market is segmented into laser therapy, electrical simulation, external shock wave therapies and saline mist therapy.
• Based on wound type, the market is segmented into surgical wound, diabetic ulcer, burns, pressure ulcer, venous ulcer among others.
• On the basis of end users, the market is classified into hospitals, wound care centers, ambulatory centers, home healthcare, clinics, and community healthcare.
• On the basis of end user the market is segmented into direct tenders, and retails.
• On the basis of distribution channel the market is segmented into direct tenders, and retails.

Contents

1. INTRODUCTION

1.1. OVERVIEW OF EUROPE ADVANCED WOUND CARE MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS
  3.1.1. RISING AGING AND GERIATRIC POPULATION
  3.1.2. TECHNOLOGICAL ADVANCEMENT
  3.1.3. GOVERNMENT SUPPORT
  3.1.4. RISING INCIDENCES OF CHRONIC WOUND
  3.1.5. INCREASING TREND
3.2. RESTRAINTS
  3.2.1. LOW AWARENESS
  3.2.2. SLOW GROWTH RATE AND SHRINKING MARKET
  3.2.3. COMPLEX REGULATORY APPROVAL PROCESS
  3.2.4. COMPETITION WITH OTHER MOIST DRESSINGS
3.3. OPPORTUNITIES
  3.3.1. REIMBURSEMENT
  3.3.2. MERGERS AND ACQUISITIONS TO EXPAND BUSINESS
  3.3.3. UNMET NEED
  3.3.4. INCREASING DEMAN
3.4. CHALLENGE
  3.4.1. SHORTAGE OF TRAINED STAFF
  3.4.2. THE DEVELOPMENT OF SUBSTITUTE PRODUCTS
3.5. KEY MARKET TRENDS AND UPCOMMING TECHNOLOGIES
  3.5.1. SMART DRESSING WILL PUSH FUTURE GROWTH
  3.5.2. HYDROFIBER HAS BEEN THE MOST SIGNIFICANT RECENT INNOVATION
  3.5.3. ALGINATE DRESSING IS EXPECTED TO GROW ROBUSTLY IN THE UPCOMING YEARS
  3.5.4. FOAM DRESSING ACCOUNTING THE LARGEST MARKET SEGMENT IN THE UPCOMING YEARS

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. EUROPE ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE

6.1. OVERVIEW
6.2. DRESSING
6.3. BIOLOGICS
6.4. THERAPY DEVICES

7. EUROPE ADVANCED WOUND CARE MARKET, BY WOUND TYPE

7.1. INTRODUCTION
7.2. SURGICAL WOUND
  7.2.1. CLASS I
  7.2.2. CLASS II
  7.2.3. CLASS III
  7.2.4. CLASS IV
7.3. DIABETIC ULCERS
7.4. PRESSURE ULCERS
7.5. VENOUS ULCERS
7.6. BURNS

8. EUROPE ADVANCED WOUND CARE MARKET, BY END USER

8.1. OVERVIEW

9. EUROPE ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL

9.1. OVERVIEW

10. EUROPE ADVANCED WOUND CARE MARKET, BY GEOGRAPHY

10.1. OVERVIEW
10.2. EUROPE ADVANCED WOUND CARE MARKET
  10.2.1. GERMANY ADVANCED WOUND CARE MARKET
  10.2.2. FRANCE ADVANCED WOUND CARE MARKET
  10.2.3. U.K. ADVANCED WOUND CARE MARKET
  10.2.4. ITALY ADVANCED WOUND CARE MARKET
  10.2.5. SPAIN ADVANCED WOUND CARE MARKET
  10.2.6. SWITZERLAND ADVANCED WOUND CARE MARKET
  10.2.7. NETHERLANDS ADVANCED WOUND CARE MARKET
  10.2.8. RUSSIA ADVANCED WOUND CARE MARKET
  10.2.9. BELGIUM ADVANCED WOUND CARE MARKET
  10.2.10. TURKEY ADVANCED WOUND CARE MARKET
  10.2.11. REST OF EUROPE ADVANCED WOUND CARE MARKET

11. EUROPE ADVANCED WOUND CARE MARKET, COMPANY SHARE

11.1. COMPANY SHARE ANALYSIS: EUROPE
11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3. COMPANY SHARE ANALYSIS: EUROPE
11.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC (APAC)
11.5. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA (MEA)
11.6. COMPANY SHARE ANALYSIS: SOUTH AMERICA

12. COMPANY PROFILES

12.1. ACELITY L.P. INC.
  12.1.1. COMPANY OVERVIEW
  12.1.2. REVENUE ANALYSIS
  12.1.3. PRODUCT PORTFOLIO
  12.1.4. RECENT DEVELOPMENTS
12.2. SMITH AND NEPHEW
  12.2.1. COMPANY OVERVIEW
  12.2.2. REVENUE ANALYSIS
  12.2.3. PRODUCT PORTFOLIO
  12.2.4. RECENT DEVELOPMENTS
12.3. MOLNLYCKE HEALTHCARE
  12.3.1. COMPANY OVERVIEW
  12.3.2. REVENUE ANALYSIS
  12.3.3. PRODUCT PORTFOLI
  12.3.4. RECENT DEVELOPMENTS
12.4. CONVATEC INC.
  12.4.1. COMPANY OVERVIEW
  12.4.2. REVENUE ANALYSIS
  12.4.3. PRODUCT PORTF
  12.4.4. RECENT DEVELOPMENTS
12.5. 3M
  12.5.1. COMPANY OVERVIEW
  12.5.2. REVENUE ANALYSIS
  12.5.3. PRODUCT PORTFOLIO
  12.5.4. RECENT DEVELOPMENTS
12.6. BAXTER
  12.6.1. COMPANY OVERVIEW
  12.6.2. REVENUE ANALYSIS
  12.6.3. PRODUCT PORTFOLIO
  12.6.4. RECENT DEVELOPMENTS
12.7. COLOPLAST
  12.7.1. COMPANY OVERVIEW
  12.7.2. REVENUE ANALYSIS
  12.7.3. PRODUCT PORTFOLIO
  12.7.4. RECENT DEVELOPMENTS
12.8. ETHICON INC
  12.8.1. COMPANY OVERVIEW
  12.8.2. REVENUE ANALYSIS
  12.8.3. PRODUCT PORTFOLIO
  12.8.4. RECENT DEVELOPMENTS
12.9. INTEGRA LIFE SCIENCES CORPORATION
  12.9.1. COMPANY OVERVIEW
  12.9.2. REVENUE ANALYSIS
  12.9.3. PRODUCT PORTFOLIO
  12.9.4. RECENT DEVELOPMENTS
12.10. DERMA SCIENCES INC
  12.10.1. COMPANY OVERVIEW
  12.10.2. REVENUE ANALYSIS
  12.10.3. PRODUCT PORTFOLIO
  12.10.4. RECENT DEVELOPMENTS
12.11. PAUL HARTMANN LIMITED
  12.11.1. COMPANY OVERVIEW
  12.11.2. REVENUE ANALYSIS
  12.11.3. PRODUCT PORTFOLIO
12.12. ORGANOGENESIS INC
  12.12.1. COMPANY OVERVIEW
  12.12.2. REVENUE ANALYSIS
  12.12.3. PRODUCT PORTFOLIO
  12.12.4. RECENT DEVELOPMENTS

13. RELATED REPORTS

COMPNIES PROFILES

Smith and Nephew Plc.Acelity L.P., Inc.Mölnlycke Health Care Coloplast Corp.ConvaTec, Inc.3M Health careMedtronicIntegra Lifesciences Corporation